跳至主要内容
临床试验/NCT02224144
NCT02224144已完成2 期

A Comparative Trial of Calcitriol Versus Placebo for the Preservation of Bone Mass and Strength After Kidney Transplantation

Columbia University1 个研究点 分布在 1 个国家目标入组 61 人开始时间: 2014年8月18日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
61
试验地点
1
主要终点
Percent Change in Bone Density From Pre to Post-calcitriol Treatment Compared to Placebo as Assessed by Both Standard Methodologies

研究概览

简要总结

The purpose of this study is to test whether active vitamin D (calcitriol) protects bones from weakening and protects blood vessels from calcium deposits over the first year of kidney transplantation.

详细描述

Kidney transplant recipients at highest fracture risk, as determined by epidemiologic studies (Caucasians and older recipients). Rocaltrol (calcitriol) is a synthetic vitamin D analog which is active in the regulation of the absorption of calcium from the gastrointestinal tract and its utilization in the body.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age older than 18
  • Self-describes as White race

排除标准

  • Lower extremity amputations
  • Non-ambulatory
  • Paget´s disease of bone
  • Current hyperthyroidism, untreated hypothyroidism
  • Medical diseases (end stage liver, intestinal malabsorption)
  • Use within the prior year pod anti-seizure medications that induce the cytochrome P450 system, testosterone, estrogen, selective estrogen receptor modulators
  • Weight >300 pounds
  • Dual organ transplant
  • Myocardial infarction or stroke
  • Tobacco use within the past year

研究组 & 干预措施

Vitamin D3 plus Calcitriol

Experimental

1 pill of Vitamin D3 (cholecalciferol) 1000 IU daily for 12 months

1 pill of Rocaltrol (calcitriol) 0.5 mcg daily for 12 months

干预措施: Vitamin D3 (Drug)

Vitamin D3 plus Calcitriol

Experimental

1 pill of Vitamin D3 (cholecalciferol) 1000 IU daily for 12 months

1 pill of Rocaltrol (calcitriol) 0.5 mcg daily for 12 months

干预措施: Calcitriol (Drug)

Vitamin D3 plus Placebo

Placebo Comparator

1 pill of Vitamin D3 (cholecalciferol) 1000 IU per day for 12 months

1 pill of placebo (sugar pill) per day for 12 months

干预措施: Vitamin D3 (Drug)

Vitamin D3 plus Placebo

Placebo Comparator

1 pill of Vitamin D3 (cholecalciferol) 1000 IU per day for 12 months

1 pill of placebo (sugar pill) per day for 12 months

干预措施: Placebo (Drug)

结局指标

主要结局

Percent Change in Bone Density From Pre to Post-calcitriol Treatment Compared to Placebo as Assessed by Both Standard Methodologies

时间窗: Baseline, 12 months

Novel high resolution bone imaging can separately measure and quantify cortical and trabecular responses to bone active treatments. Finite element analysis (FEA) can be applied to HRpQCT datasets. to provide a computational estimate of bone mechanical competence that has been validated against true compressive tests of bone stiffness and strength.

次要结局

  • Percent Change in Areal Bone Mass Density From Baseline to 12 Months After Transplantation(Baseline, 12 months)
  • Percent Change in Failure Load Pre- and Post-transplantation Measured by High Resolution Imaging Methods(Baseline, 12 months)
  • Percent Change of Cortical Porosity Pre- and Post-intervention(Baseline, 12 months)
  • Percent Change in Vascular Calcifications Loads of the Lower Extremity(Baseline, 12 months)
  • Number of Patients With Vascular Calcifications of the Lower Extremity(Baseline, 12 months)
  • Percent Change in Pre- and Post- Intervention Parathyroid Hormone (PTH) Levels(Baseline, 12 months)
  • Percent Change in Pre- and Post- Intervention Levels of Bone Remodeling Markers for Bone Remodeling Assessment(Baseline, 12 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验